Uncategorized

Olainfarm’s Sales in February are 8 Million Euros

on March 15, 2017

Preliminary consolidated results of JSC Olainfarm for February 2017 show that sales of the group have reached 8 million euros, which represents a reduction by 8% compared to the same period of 2016. The biggest sales increases were achieved in Georgia, where sales grew by 25% and in Russia, where sales grew by 23%. The biggest reduction in sales took place in Ukraine, where sales shrunk by 33% and in Lithuania, where sales were for 30% smaller this year. Significant shipments during this period were also made to Bulgaria, Moldova and Germany. The major sales markets of the group in February 2017 were Russia, Latvia, Ukraine and Belarus.

February 2017, consolidated sales Sales, thsnd. EUR Changes to February 2016 Share in total sales
Russia 2 617 23% 33%
Latvia 2 498 9% 31%
Ukraine 1 052 -33% 13%
Belarus 867 -6% 11%
Kazakhstan 137 -24% 2%
Bulgaria 114 NA 1%
Moldova 97 NA 1%
Lithuania 88 -30% 1%
Germany 86 NA 1%
Georgia 65 35% 1%
Other 385 -60% 5%
Total 8 006 -3% 100%

 

Sales by pharmacies of Latvijas aptieka Ltd. in February 2017 were 1.68 million euros, which represents a reduction by 3% compared to the same period one year ago. Sixty-eight pharmacies were operating during February. Sales of Silvanols Ltd. during February 2017 were .57 million euros, which is an increase by 21% compared to 2016. During this period, Silvanols Ltd. sold its products to six European countries and with assistance of JSC Olainfarm also to Belarus. Sales of Tonus Elast Ltd. in February were 0.77 million euros. This company sold its products to 17 countries in three continents.

During the first two months of 2017, the consolidated sales of the group reached 17.1 million euros, which represents an increase by 0.3% compared to consolidated sales of two months of 2016. The biggest sales increases were achieved in Georgia, where sales grew by 327% and in The Netherlands, where sales grew by 258%. The biggest reduction in sales took place in Ukraine, where sales shrunk by 42% and in Kazakhstan, where sales shrunk by 37%. The major sales markets of AS Olainfarm in two months of 2017 were Russia, Latvia, Belarus and Ukraine.

2 months of 2017, consolidated sales Sales, thsnd. EUR Changes to 2 months of 2016 Share in total sales
Russia 4 958 13% 29%
Latvia 4 949 13% 29%
Belarus 2 481 3% 14%
Ukraine 1 369 -42% 8%
The Netherlands 912 258% 5%
Poland 288 25% 2%
Germany 287 45% 2%
Lithuania 255 35% 1%
Kazakhstan 246 -37% 1%
Georgia 205 327% 1%
Other 1 165 -46% 7%
Total 17 116 0% 100%

 

Sales of pharmacies of Latvijas aptieka Ltd. in two months of 2017 were 3.4 million euros, which is comparable to their sales during the same period of 2016. Sales of Silvanols Ltd. during two months was 1.06 million euros, which represents an increase by 34% compared to two months of last year, when Silvanols’ sales were 0.79 million euros. Silvanols Ltd. sold its products to nine European countries, and, with the help of JSC Olainfarm, also to Russia and Belarus. Sales of Tonus Elast Ltd. in two months of 2017 were 0.94 million euros. This company made its sales to 21 countries in four continents.

According to unconsolidated preliminary results, sales of JSC Olainfarm during February 2017 were 6 million euros, which represents a reduction by 14% compared to the same period of 2016. The biggest sales increases were achieved in Azerbaijan, where sales grew by 67% and in Russia, where sales grew by 8%. The biggest sales reductions took place in Kazakhstan, where sales shrunk by 64% and in Lithuania, where sales shrunk by 39%. During February 2017, significant shipments were also made to Bulgaria, Germany and Moldova. The major sales markets during this period were Russia, Latvia, Ukraine and Belarus. In total JSC Olainfarm sold its products to 23 countries in Europe and Asia.

February, 2017, unconsolidated sales Sales, thsnd. EUR Changes to February, 2016 Share in total sales
Russia 2 288 8% 38%
Latvia 1 212 7% 20%
Ukraine 1 052 -30% 18%
Belarus 853 -8% 14%
Bulgaria 106 NA 2%
Germany 86 NA 1%
Lithuania 66 -39% 1%
Kazakhstan 65 -64% 1%
Moldova 55 NA 1%
Azerbaijan 41 67% 1%
Other 164 -83% 3%
Total 5 988 -14% 100%

 

According to unconsolidated preliminary results, sales of JSC Olainfarm in two months of 2017 were 13.7 million euros, which represents a reduction by 7% compared to the same period of 2016. The biggest sales increases were achieved in The Netherlands, where sales grew by 258% and in Georgia, where sales grew by 229%. The biggest sales reduction took place in Kazakhstan, where sales shrunk by 62% and in Ukraine, where sales shrunk by 40%. Biggest sales markets of JSC Olainfarm in two months of 2017 were Russia, Latvia, Belarus and Ukraine. In total in two months of 2017, JSC Olainfarm sold its products to 33 countries in four continents.

2 months of 2017, unconsolidated sales Sales, thsnd. EUR Changes to 2 months of 2016 Share in total sales
Russia 4 628 6% 34%
Latvia 2 491 7% 18%
Belarus 2 467 1% 18%
Ukraine 1 369 -40% 10%
The Netherlands 913 258% 7%
Germany 284 43% 2%
Poland 264 47% 2%
Lithuania 208 34% 2%
Georgia 159 229% 1%
Kazakhstan 150 -62% 1%
Other 792 -61% 6%
Total 13 725 -7% 100%

 

According to preliminary estimates, unconsolidated sales of JSC Olainfarm in 2017 might reach 96 million euros, while consolidated sales might reach 127 million euros. According to the preliminary sales numbers published here, during two months of 2017, the company has already made 14% of its unconsolidated sales estimate and 13% of its annual consolidated sales estimate.

 

JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with more than 45 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company’s operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 40 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.

 

Information prepared by:
Salvis Lapins
JSC Olainfa
Member of the Management Board
Rupnicu iela 5, Olaine, Latvia, LV 2114
Phone: +371 6 7013 717
Fax: +371 6 7013 777
E-mail: Salvis.Lapins@olainfarm.lv

 

read more
Eva DombrovskaOlainfarm’s Sales in February are 8 Million Euros

Olainfarm Goes on a Road Show to Baltic, Nordic and Polish Investors

on October 24, 2016

From October 24 through October 28 Member of the Board and Investor relations officer of JSC Olainfarm Mr. Salvis Lapins will have his third annual road show to update investors about Olainfarm’s performance and near future intentions. Presentations will be organized in capitals of six countries. For the first time road show will also include Warsaw and Copenhagen

„This is the third year when at the end of October we organize road show to meet our investors. We report on what has happened during the year and discuss our vision about our future development. I am delighted that the event is becoming increasingly popular among the investors and that the geography of interest is also expanding, as this year investors from Poland and Denmark have also expressed interest,” says Salvis Lapins, Member of Olainfarm’s Board and company’s Investor Relations Officer.

Meetings are planned on October 24 in Vilnius, October 25 in Warsaw, October 26 in Copenhagen and in Stockholm, October 27 in Helsinki and October 28 in Tallinn. More than 20 meetings have been scheduled so far and during those meetings the enclosed presentation will be distributed: Baltic Sea Region Roadshow Presentation.

 

 

JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with more than 40 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company’s operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 40 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.

 

 

Information prepared by:
Salvis Lapins
JSC Olainfarm
Member of the Management Board
Rupnicu iela 5, Olaine, Latvia, LV 2114
Phone: +371 6 7013 717
Fax: +371 6 7013 777
E-mail: Salvis.Lapins@olainfarm.lv

read more
SigitaOlainfarm Goes on a Road Show to Baltic, Nordic and Polish Investors

Olainfarm Named the Best Listed Company in Baltics

on October 14, 2016

JSC Olainfarm was named the best listed company in the Baltics and has received “Baltic Corporate Excellence Award”. This is the first time Latvian company has received this Baltic award. Previous seven years award stayed in Lithuania. Last year the award winner was Lithuanian company Apranga. JSC Olainfarm was also named the best listed company in Latvia, an honour that Olainfarm has been awarded fifth year in a row. Olainfarm was appreciated this high for its ability to successfully operate despite unfavourable economic conditions in its main markets, and for its growth potential, backed by company’s diversification strategy in terms of geography, products and business segments.

Lithuanian clothing retailer Apranga was Baltic runner up this year and the best listed company in Lithuania. Estonian electrical engineering company Harju Elekter was named the best listed company of Estonia and the third best in the Baltics.

It is ninth consecutive years since Riga office of Swiss based analysts of CE Services in partnership with CE Asset Management AG and BA School of Business and Finance make comprehensive qualitative and quantitative analyses of companies listed on the official list of Nasdaq Baltic. The goal of the analyses is to identify the best company in Baltics depending on its historical financial indicators, competitiveness and quality of corporate governance. This year, the quality part of analysis was expanded by including factors of corporate social responsibility, as investors pay increasing attention to it.

Photo: Salvis Lapins, Member of the Management Board of JSC Olainfarm

 

JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with more than 40 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company’s operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 40 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.

 

Information prepared by:
Salvis Lapins
JSC Olainfarm
Member of the Management Board
Rupnicu iela 5, Olaine, Latvia, LV 2114
Phone: +371 6 7013 717
Fax: +371 6 7013 777
E-mail: Salvis.Lapins@olainfarm.lv

read more
SigitaOlainfarm Named the Best Listed Company in Baltics

Notification of Olainfarm on Home Member State

on September 29, 2016

Notification of AS Olainfarm on Home Member State

  1. Issuers Name: AS Olainfarm

Formerly known as AS Olaines Kimiski Farmaceitiska Rupnica

  1. Registered office: Rupnicu iela 8, Olaine, Latvia, LV 2114
  2. National company register number:  40003007246
  3. Home Member State: Latvia
  4. Triggering event: Issuer of shares admitted to trading
  5. Member State where the issuer’s securities are admitted to trading: 

                         

Shares            Debt securities                      Other securities

Latvia              14 850 780

  1. NCAs the form is required to be filed with: The Financial and Capital Market Commission, Latvia
  2. Date of notification: 29.09.2016
  3. Contact details:

Issuer`s address: Rupnicu iela 5, Olaine, Latvia, LV-2114
Person responsible within the issuer for the present notification: Salvis Lapins
E-mail address: Salvis.Lapins@olainfarm.lv
Telephone: +371 26448873

Dalibvalsts-EN

Information prepared by:
Salvis Lapins
JSC Olainfarm
Member of the Management Board
Rupnicu iela 5, Olaine, Latvia, LV 2114
Phone: +371 6 7013 717
Fax: +371 6 7013 777
E-mail: Salvis.Lapins@olainfarm.lv

read more
SigitaNotification of Olainfarm on Home Member State

Sales of Olainfarm in August were 6.76 Million Euros

on September 15, 2016

Preliminary consolidated results of JSC Olainfarm for August 2016 show that sales of the company were 6.76 million euros, which represents an increase by 1% compared to the same period of 2015. The biggest sales increase was achieved in Czech Republic, where sales grew by 1866%. Sales to Ukraine grew by 182% while sales to Uzbekistan grew by 147%. During August 2016, JSC Olainfarm also made significant shipments to Brazil, and Germany. The major sales markets in August were Latvia, Russia, Ukraine and Belarus.

August 2016, consolidated sales Sales, thsnd. EUR Changes to August, 2015 Share in total sales
Latvia 2 179 33% 32%
Russia 1 366 -48% 20%
Ukraine 964 182% 14%
Belarus 495 -44% 7%
Uzbekistan 301 147% 4%
Czech Republic 250 1866% 4%
Kazakhstan 209 29% 3%
Brazil 120 NA 2%
Lithuania 80 -17% 1%
Germany 76 NA 1%
Other 720 -11% 11%
Total 6 760 1% 100%

 

Sales of pharmacy chain of Latvijas aptieka Ltd. in August were 1.47 million euro, which represents an increase by 18% compared to the same period of last year. Sixty two pharmacies were operating during august 2016. Sales of  Silvanols Ltd. during August 2016 were 0.36 million euro, which represents an increase by 57% compared to August of 2015. Silvanols Ltd. was selling its products in six European countries and with the help of JSC Olainfarm also to Lithuania, Azerbaijan and Russia. Sales of Tonus Elast Ltd. during August 2016 were 0.76 million euros. The company sold its products to 23 countries in four continents.

According to preliminary consolidated numbers, the amount of sales of JSC Olainfarm in eight months of 2016 was 70.35 million euro, which represents an increase by 8% compared to eight months of 2015. The biggest sales increase was achieved in Uzbekistan, where sales grew by 112%. Sales to Poland increased by 75%, while sales to Ukraine increased by 51%. The major sales markets in eight months were Russia, Latvia, Ukraine and Belarus.

Eight months of 2016, consolidated sales Sales, thsnd. EUR Changes to eight months of 2015 Share in total sales
Russia 20 946 -6% 30%
Latvia 16 436 13% 23%
Ukraine 11 488 51% 16%
Belarus 5 771 23% 8%
Uzbekistan 1 751 112% 2%
UK 1 589 4% 2%
Kazakhstan 1 568 -4% 2%
The Netherlands 1 090 -76% 2%
Turkmenistan 1 067 38% 2%
Poland 992 75% 1%
Other 7 647 31% 11%
Total 70 345 8% 100%

 

Sales of pharmacy chain of Latvijas aptieka Ltd. in eight months was 12.3 million euros, which is an increase by 14% compared to eight months of 2015. Sales of Silvanols Ltd. in eight months of 2016 were 3.1 million euros, which represents an increase by 29%, as last year during this period sales of Silvanols Ltd. were 2.4 million euros. Products of Silvanols Ltd. during this period were sold to eleven European countries and with a help of JSC Olainfarm also to Albania, Kosovo, Azerbaijan, Kazakhstan, Belarus and Russia. Sales of Tonus Elast Ltd. in three months was 2.1 million euros. Its products were sold to 28 countries in four continents.

According to preliminary unconsolidated data, sales of JSC Olainfarm during August 2016 were 4.94 million euros, which represents a reduction by 16% compared to sales made during August of 2015. The biggest sales increase was achieved in Ukraine, where sales grew by 182%, while sales to Uzbekistan grew by 147%. Major sales markets of JSC Olainfarm during August 2016 were Russia, Latvia, Ukraine and Belarus. During August 2016, products of JSC Olainfarm were sold to 25 countries in three continents.

August, 2016, consolidates sales Sales, thsnd. EUR Changes to August 2015 Share in total sales
Russia 1 366 -48% 28%
Latvia 1 094 21% 22%
Ukraine 964 182% 20%
Belarus 483 -45% 10%
Uzbekistan 301 147% 6%
Kazakhstan 121 -26% 2%
Brazil 120 NA 2%
Lithuania 79 -10% 2%
Germany 73 NA 1%
Bulgaria 62 NA 1%
Other 274 -63% 6%
Total 4 937 -16% 100%

 

According to unconsolidated preliminary numbers, sales of JSC Olainfarm in eight months of 2016 were 59.65 million euros, which represents an increase by 4% compared to the same period of 2015. The biggest sales increase during this period was achieved in Uzbekistan, where sales grew by 112%. Sales to Ukraine grew by 50%, and sales to Lithuania grew by 44%. Major sales markets of JSC Olainfarm during this period were Russia, Ukraine, Latvia and Belarus. In total, during this eight months period products of JSC Olainfarm were sold to 38 countries in four continents.

Wight months of 2016, unconsolidated sales Sales, thsnd. EUR Changes to eight months of 2015 Share in total sales
Russia 20 545 -8% 34%
Ukraine 11 404 50% 19%
Latvia 8 739 9% 15%
Belarus 5 748 23% 10%
Uzbekistan 1 751 112% 3%
UK 1 540 1% 3%
Kazakhstan 1 336 -18% 2%
The Netherlands 1 090 -76% 2%
Turkmenistan 1 067 38% 2%
Lithuania 742 44% 1%
Other 5 692 17% 10%
Total 59 654 4% 100%

 

AGM of AS Olainfarm held on June 7, this year approved operating plan of the Company and the Group, providing that Company’s sales in 2016 will reach 86 million euros, while Group’s sales will reach 100 million euros. According to these preliminary sales numbers, in eight months of 2016 sixty nine percent of planned annual Company’s sales and 70% percent of planned annual Group’s sales have been attained.

 

JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with more than 40 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company’s operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 40 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.

 

Information prepared by:
Salvis Lapins
JSC Olainfarm
Member of the Management Board
Rupnicu iela 5, Olaine, Latvia, LV 211
Phone: +371 6 7013 717
Fax: +371 6 7013 777
E-mail: Salvis.Lapins@olainfarm.lv

read more
SigitaSales of Olainfarm in August were 6.76 Million Euros

Recording of the Second Quarter 2016 Investor Conference Webinar

on September 13, 2016

On September 12 JSC Olainfarm organized its Investor Conference Online Webinar. During the webinar the member of the management board of JSC Olainfarm Salvis Lapiņš analyzed the financial results of second quarter 2016 and informed about other recent activities within the company.

The recorded Olainfarm webinar is available online: http://ej.uz/OLF_Q2_2016_rec, and the presentation, demonstrated during the webinar, is available in the previously published company’s announcement: http://ej.uz/OLF_Q2_2016_PDF.

Olainfarm thanks all participants, who joined the webinar, and encourages everybody to follow company’s announcements to get information on the next webinar!

 

JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with more than 40 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company’s operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 40 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.

 

Information prepared by:
Salvis Lapins
JSC Olainfarm
Member of the Management Board
Rupnicu iela 5, Olaine, Latvia, LV 2114
Phone: +371 6 7013 717
Fax: +371 6 7013 777
E-mail: Salvis.Lapins@olainfarm.lv

read more
SigitaRecording of the Second Quarter 2016 Investor Conference Webinar

Olainfarm holds Second Quarter 2016 Investor Conference Webinar

on September 12, 2016

JSC Olainfarm invites shareholders, investors, mass media representatives and other stakeholders to join its investor conference webinar scheduled on September 12, 2016 at 16:00 (EEST). Please note that attendees have to register for the webinar in advance – detailed information on the registration process is available below.

Webinar will be hosted by the Member of the Management Board Salvis Lapiņš. The presentation will be held in English.

During the webinar Salvis Lapiņš will inform about JSC Olainfarm activities and financial results of second quarter of 2016. After the presentation investors are welcome to ask questions. During the webinar the enclosed presentation will be presented: Webinar Presentation: 2nd quarter and 6 months of 2016

To follow the webinar, you will need a computer with an internet connection and headphones. To join the webinar, you need to register in advance via http://ej.uz/OLF_Q2_2016.

You will be provided with the webinar link and instructions to join webinar successfully. When joining the webinar for the first time, you will be asked to download the system application on your computer which will take only few seconds.

A corporate webinar is a virtual conference, during which a company’s representative provides information about the company, its activities and future plans. A webinar provides an opportunity to receive information directly from the company while being located anywhere, as well as to receive answers to questions of interest to you. For more information on webinar service please visit: www.nasdaqbaltic.com/en/products-services/webinars-3/.

Join the webinar and be the first one to hear the news!

 

JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with more than 40 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company’s operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 40 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.

Information prepared by:
Salvis Lapins
JSC Olainfarm
Member of the Management Board
Rupnicu iela 5, Olaine, Latvia, LV 2114
Phone: +371 6 7013 717
Fax: +371 6 7013 777
E-mail: Salvis.Lapins@olainfarm.lv

read more
SigitaOlainfarm holds Second Quarter 2016 Investor Conference Webinar

Olainfarm has Acquired 24% Shares in NPK Biotest, a Belarus Based Company

on September 8, 2016

JSC Olainfarm has acquired 24% shares in Belarussian pharmaceutical company NPK Biotest. It is planned that in the nearest future Olainfarm will acquire another 46% shares, thus increasing its holdings to 70%. For the whole 70% share in the company Olainfarm agreed to pay 2.6 million euros. The acquisition will allow JSC Olainfarm to place some of its production processes in Belarus.

“We plan to have NPK Biotest not only as our production platform, helping us and our daughter companies to have easier access to Belarus market, but the acquisition will also add Group’s product portfolio with numerous herbal teas and their mixtures,“ says Valerijs Maligins, Chairman of the Board of JSC Olainfarm.

NPK Biotest is one of the first private pharmaceutical companies in Belarus. Group of scientists of Belarussian Academy of Sciences established it in 1990 in Hrodna. The company now is producing natural herbal medicines and food supplements. Its product portfolio includes more than 100 herbal teas, mixtures and powders. NPK Biotest owns four pharmacies in Hrodna. Company’s sales in 2015 were 2.7 million euros.

Olainfarm Group includes Latvian green pharma company Silvanols, chain of pharmacies of Latvijas aptieka, producer of elastic medical products Tonus Elast and producer of eco-cosmetics Kiwi Cosmetics.

Consolidated profit of Olainfarm in 2015 was 15.3 million euros, which is an increase by 25% compared to 2014 and by 8% compared to 2012, when the previous profit record of 14.2 million was set. Major sales markets of the Group in 2015 were Russia, Latvia, Ukraine, Belarus and The Netherlands.

 

JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with more than 40 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company’s operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 40 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.

 

Information prepared by:
Salvis Lapins
JSC Olainfarm
Member of the Management Board
Rupnicu iela 5, Olaine, Latvia, LV 2114
Phone: +371 6 7013 717
Fax: +371 6 7013 777
E-mail: Salvis.Lapins@olainfarm.lv

read more
SigitaOlainfarm has Acquired 24% Shares in NPK Biotest, a Belarus Based Company

Olainfarm will hold Second Quarter 2016 Investor Conference Webinar

on September 8, 2016

JSC Olainfarm invites shareholders, investors, mass media representatives and other stakeholders to join its investor conference webinar scheduled on September 12, 2016 at 16:00 (EEST). Please note that attendees have to register for the webinar in advance – detailed information on the registration process is available below.

Webinar will be hosted by the Member of the Management Board Salvis Lapiņš. The presentation will be held in English.

During the webinar Salvis Lapiņš will inform about JSC Olainfarm activities and financial results of second quarter of 2016.

After the presentation investors are welcome to ask questions. Due to the limited webinar time, please send in your questions in advance till September 11 to e-mail: ieva.unda@nasdaq.com.

To follow the webinar, you will need a computer with an internet connection and headphones. To join the webinar, you need to register in advance via http://ej.uz/OLF_Q2_2016.

You will be provided with the webinar link and instructions to join webinar successfully. When joining the webinar for the first time, you will be asked to download the system application on your computer which will take only few seconds.

A corporate webinar is a virtual conference, during which a company’s representative provides information about the company, its activities and future plans. A webinar provides an opportunity to receive information directly from the company while being located anywhere, as well as to receive answers to questions of interest to you. For more information on webinar service please visit: www.nasdaqbaltic.com/en/products-services/webinars-3/.

Join the webinar and be the first one to hear the news!

 

JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with more than 40 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company’s operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 40 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.

Information prepared by:
Salvis Lapins
JSC Olainfarm
Member of the Management Board
Rupnicu iela 5, Olaine, Latvia, LV 2114
Phone: +371 6 7013 717
Fax: +371 6 7013 777
E-mail: Salvis.Lapins@olainfarm.lv

read more
SigitaOlainfarm will hold Second Quarter 2016 Investor Conference Webinar

Meet Olainfarm at the CPhI 2016 in Barcelona at Hall 5 Stand 5J18

on September 9, 2016

We are pleased to invite you to visit our stand 5J18 at Hall 5 at the CPhI 2016 in Barcelona, between 4th&6th October 2016.

Olainfarm will be on site showcasing our portfolio of FDFs, APIs and intermediates. We offer complete contract manufacturing services including research, scale-up, pilot and commercial manufacturing, as well as support with QC and validation. Our top level management will be available to discuss business with you straight away. If you are interested in setting up a meeting, please contact us stating your topic of interest, and we will reserve a timeslot for you at your preferred day and time.

Olainfarm is the leading manufacturer in the chemical and pharmaceutical sector of the Baltic States with more than 40 years of experience and export to more than 40 countries worldwide. Our key areas of specialization in FDFs include neurology, cardiology, infectology and allergology. We have a long-standing technological and know-how advantage in adamantane chemistry, quinuclidine chemistry, nitrofurane chemistry and optically pure g-aminobutyric acid derivatives, as well as in chiral compounds.

If you require any assistance or further information, please feel free to contact us:
Sigita Zviedre
Head of PR
Mobile: +371 26377286
E-mail: slapsina@olainfarm.lv

read more
SigitaMeet Olainfarm at the CPhI 2016 in Barcelona at Hall 5 Stand 5J18